Breast Cancer

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer [Phase 2]

  A Phase 2 trial evaluating eribulin with or without a trastuzumab biosimilar in patients with HER2-overexpressing recurrent or stage IV brea…

• CLINICAL_TRIALS trial_result · 2025-11-20
  Clinical Trial Update: A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

  An update on a study investigating peripheral neuropathy associated with ado-trastuzumab emtansine (T-DM1) in patients with HER2-positive br…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC

  This trial evaluates HER2-PET imaging as a precision tool to guide treatment with a HER2-targeted antibody-drug conjugate in metastatic brea…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer [Phase 2]

  Phase 2 trial update exploring a chemotherapy-free, pCR-guided strategy using trastuzumab, pertuzumab, and T-DM1 in HER2-positive early brea…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Estradiol Plus Olaparib for Breast Cancer (PHOEBE) [Phase 1]

  A Phase 1 clinical trial (PHOEBE) is testing estradiol in combination with olaparib for metastatic breast cancer and is currently recruiting…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer [NA]

  This entry reports on an ongoing clinical trial evaluating individual sensitivity to chemotherapy-induced gonadotoxicity in young patients w…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer [Phase 2]

  A Phase 2 sustainable and efficient platform trial for developing therapies in early breast cancer is currently recruiting.

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors [NA]

  An update on an ongoing study testing a mobile health physical activity program with mindful awareness lessons for breast cancer survivors. …

• CLINICAL_TRIALS trial_result · 2025-11-20
  Clinical Trial Update: Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) [NA]

  This clinical trial update notes a completed study evaluating an automated system to culture metastatic circulating tumor cells in embryonat…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer [Phase 4]

  Phase 4 clinical trial update evaluating harms and benefits of endocrine therapy in patients aged 70 and older with lower-risk breast cancer…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR [NA]

  This clinical trial update describes a study evaluating drain removal on postoperative safety and patient satisfaction in R-E-NSM with prepe…

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients [NA]

  This ClinicalTrials.gov update describes a cohort study investigating the combination of cryoablation and thermal ablation as a non-surgical…

• CLINICAL_TRIALS research · 2025-11-19
  Clinical Trial Update: Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. [NA]

  MD Anderson Cancer Center is recruiting for a study to identify underserved Texans at hereditary cancer risk using mobile mammography units …

• CLINICAL_TRIALS trial_result · 2025-11-19
  Clinical Trial Update: Living Conditions and Breast Cancer

  This clinical trial update indicates that the study on living conditions and breast cancer has completed.

• CLINICAL_TRIALS research · 2025-11-19
  Clinical Trial Update: Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction [NA]

  This clinical trial update outlines a planned study at Beaumont Hospital to evaluate well-being and patient-reported outcomes after robotic …

• CLINICAL_TRIALS research · 2025-11-19
  Clinical Trial Update: Scalp Cooling in MBC [Phase 2]

  Phase 2 clinical trial from Dana-Farber Cancer Institute evaluating scalp cooling to prevent chemotherapy-induced alopecia in patients with …

• CLINICAL_TRIALS trial_result · 2025-11-19
  Clinical Trial Update: ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer [Phase 1]

  Phase 1 trial update for ELVN-002 with trastuzumab (± chemotherapy) in HER2-positive breast cancer, gastric cancer, and colorectal cancer; t…

• CLINICAL_TRIALS research · 2025-11-19
  Clinical Trial Update: Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients [Phase 2]

  A Phase 2 clinical trial is evaluating whether nebivolol can protect against trastuzumab-induced cardiotoxicity in patients with HER2-positi…

• CLINICAL_TRIALS research · 2025-11-19
  Clinical Trial Update: Living Well Program: Impact on Healthcare Costs and Clinical Outcomes in Breast Cancer Care [NA]

  Clinical trial update for a Living Well Program assessing its impact on healthcare costs and clinical outcomes in breast cancer care. The st…

• CLINICAL_TRIALS research · 2025-11-19
  Clinical Trial Update: Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC [Phase 3]

  A Phase 3 trial is evaluating adjuvant abemaciclib in combination with standard endocrine therapy versus standard therapy alone in high-risk…

• CLINICAL_TRIALS trial_result · 2025-11-19
  Clinical Trial Update: Locoregional Blocks for Breast Cancer Surgeries [NA]

  A completed clinical trial evaluating locoregional blocks for analgesia in breast cancer surgery.

• CLINICAL_TRIALS trial_result · 2025-11-19
  Clinical Trial Update: A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer [Phase 2]

  Phase 2 study evaluating entinostat in combination with fulvestrant for locally advanced or metastatic breast cancer, currently not yet recr…

• CLINICAL_TRIALS trial_result · 2025-11-19
  Clinical Trial Update: NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer [Phase 2]

  A Phase 2 neoadjuvant trial comparing trastuzumab-deruxtecan against chemotherapy with trastuzumab and pertuzumab in HER2-positive early bre…

• CLINICAL_TRIALS research · 2025-11-19
  Clinical Trial Update: Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer

  A clinical trial update announcing recruitment for a study evaluating adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative…

• CLINICAL_TRIALS trial_result · 2025-11-19
  Clinical Trial Update: Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program [NA]

  Completed clinical trial evaluating whether a tailored physical exercise program can reduce cancer treatment-related toxicity in breast canc…